The distinct contributions of each receptor system - GLP-1-mediated improvements in insulin sensitivity and appetite regulation, GIP-mediated enhancement of insulin secretion and adipose tissue function, and glucagon-mediated direct hepatic metabolic modulation and increased energy expenditure - create synergistic benefits when engaged through dual or triple agonist formulations
Moreover, fasting hyperglycaemia was responsible for 2.3 million cardiovascular deaths worldwide in 2021 [2]
No standalone-vs-combination equivalence
Among the most common are gastrointestinal symptoms, such as nausea, vomiting, constipation, and diarrhea
Retatrutide, by contrast, has no current prescribing guidelines in the UK because it has not been granted a marketing authorisation
Ivm Health is not affiliated with Novo Nordisk and the compounded semaglutide products available as part of Ivim Healths weight loss programs are not made by Novo Nordisk or any company affiliated with Novo Nordisk.